Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in T2DM Patients With COVID-19
NCT04604223Phase 4Unknown
- Sponsor
- Dasman Diabetes Institute
- Start
- Jan 2021
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of pioglitazone in coronavirus disease 2019 (COVID-19), sponsored by Dasman Diabetes Institute. Status: unknown.
02
Drugs
pioglitazone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04604223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04604223.